Intervention Review

Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation

  1. Mohamed Kharfan-Dabaja1,2,
  2. Rahul Mhaskar3,
  3. Tea Reljic3,
  4. Joseph Pidala1,
  5. Janelle B Perkins4,
  6. Benjamin Djulbegovic1,5,
  7. Ambuj Kumar3,*

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 25 JUL 2014

Assessed as up-to-date: 17 MAR 2014

DOI: 10.1002/14651858.CD010280.pub2


How to Cite

Kharfan-Dabaja M, Mhaskar R, Reljic T, Pidala J, Perkins JB, Djulbegovic B, Kumar A. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD010280. DOI: 10.1002/14651858.CD010280.pub2.

Author Information

  1. 1

    H. Lee Moffitt Cancer Center, Division of Oncologic Sciences, University of South Florida, Department of Blood and Marrow Transplantation, Tampa, Florida, USA

  2. 2

    American University of Beirut, Division of Hematology-Oncology and Bone Marrow Transplantation Program, Beirut, Lebanon

  3. 3

    University of South Florida, Center for Evidence Based Medicine and Health Outcomes Research, Tampa, Florida, USA

  4. 4

    Division of Oncologic Sciences, University of South Florida, Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, Florida, USA

  5. 5

    University of South Florida, USF Clinical Translational Science Institute, Departments of Medicine, Hematology and Health Outcome Research, Tampa, Florida, USA

*Ambuj Kumar, Center for Evidence Based Medicine and Health Outcomes Research, University of South Florida, Tampa, Florida, USA. akumar1@health.usf.edu. drambujkr@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 25 JUL 2014

SEARCH

  1. Current Version

    Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation

    Mohamed Kharfan-Dabaja, Rahul Mhaskar, Tea Reljic, Joseph Pidala, Janelle B Perkins, Benjamin Djulbegovic and Ambuj Kumar

    Article first published online: 25 JUL 2014 | DOI: 10.1002/14651858.CD010280.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Mycophenolate mofetil versus methotrexate for prevention of acute graft-versus-host disease in patients receiving allogeneic hematopoietic stem cell transplantation

    Mohamed Kharfan-Dabaja, Rahul Mhaskar, Tea Reljic, Joseph Pidala, Janelle B Perkins, Benjamin Djulbegovic and Ambuj Kumar

    Article first published online: 12 DEC 2012 | DOI: 10.1002/14651858.CD010280